Austco Healthcare is acquiring Medical Communications Systems to deepen its direct sales footprint in South Australia, continuing a string of reseller takeovers that bolster its market presence and earnings.
- Acquisition of Medical Communications Systems for $2.88 million
- Adds $1.88 million revenue and $0.82 million EBITDA annually
- Continues Austco’s strategy of reseller acquisitions
- Deal includes upfront payment plus performance-based earnout
- Completion expected August 2026, funded from cash reserves
Strategic Reseller Acquisition Strengthens South Australian Presence
Austco Healthcare Limited (ASX:AHC) is bringing its long-standing South Australian reseller Medical Communications Systems (MCS) in-house for approximately $2.88 million. The move marks another step in Austco’s ongoing strategy to acquire established resellers and convert them into direct sales operations, enhancing control over customer relationships and service delivery in key regional markets.
The acquisition, structured as a cash-free, debt-free transaction, includes an upfront payment of about $2.24 million with a performance-based earnout estimated at $0.64 million, dependent on MCS’s FY27 EBITDA results. Austco expects the deal to be immediately accretive to earnings, excluding transaction and integration costs.
Financial Impact and Integration Outlook
MCS, based in Morphett Vale, South Australia, has been Austco’s certified nurse call reseller since 2011. It generated $3.33 million in revenue in FY26, with $1.45 million already recorded as Austco revenue through product supply. The acquisition adds an incremental $1.88 million in net revenue and around $0.82 million in EBITDA on a full-year basis.
Key personnel at MCS are expected to remain post-acquisition, ensuring continuity in local expertise and customer service. Austco plans to prioritise seamless integration focusing on customer retention, aligning financial systems, and maintaining service standards for South Australian healthcare and aged-care clients.
Austco’s Proven Acquisition Playbook
This acquisition follows Austco’s recent purchases of Teknocorp (2023), Amentco (2024), and G&S Technologies (2025), all reseller businesses absorbed to strengthen Austco’s direct sales and service footprint. CEO Clayton Astles highlighted the disciplined approach linking part of the purchase price to future performance, reinforcing Austco’s focus on earnings-accretive growth.
Funding for the upfront consideration will come from Austco’s existing cash reserves, reflecting the company’s strong balance sheet. Completion is contingent upon customary conditions, including securing a new lease for MCS’s premises and finalising employment agreements with key staff.
Positioning Ahead of FY26 Results
Austco will provide an update on the acquisition’s contribution alongside its FY26 full-year results due in late August 2026. The deal aligns with Austco’s broader growth trajectory, which includes a recent 52% net profit surge forecast driven by a major US hospital rollout and a string of strategic acquisitions boosting revenue and EBITDA margins.
Bottom Line?
Austco’s latest reseller acquisition consolidates its direct sales strategy in South Australia, with earnings accretion expected quickly but contingent on smooth integration and MCS’s FY27 performance.
Questions in the middle?
- How will Austco’s integration approach mitigate risks around customer and employee retention in South Australia?
- What impact will the performance-based earnout have on Austco’s FY27 cash flow and earnings volatility?
- Could Austco accelerate further reseller acquisitions to replicate this model in other Australian regions?